News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
EcoR1 Capital, LLC
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/12/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 10/02/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 07/27/2023 |
SC 13G
| EcoR1 Capital, LLC reports a 16.9% stake in Mersana Therapeutics, Inc. |
| 07/18/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 06/07/2023 |
SC 13G
| EcoR1 Capital, LLC reports a 9.9% stake in Galapagos NV |
| 02/14/2023 |
SC 13G
| EcoR1 Capital, LLC reports a 10% stake in Tempest Therapeutics Inc. |
| 01/23/2023 |
SC 13G
| EcoR1 Capital, LLC reports a 5% stake in Revolution Medicines, Inc. |
| 12/22/2022 |
SC 13G
| EcoR1 Capital, LLC reports a 8.3% stake in Adicet Bio, Inc. |
| 11/23/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 11/18/2022 |
SC 13G
| EcoR1 Capital, LLC reports a 9.8% stake in Graphite Bio, Inc. |
| 11/14/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 10/28/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 10/28/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 09/26/2022 |
SC 13G
| EcoR1 Capital, LLC reports a 5.5% stake in Edgewise Therapeutics, Inc. |
| 09/19/2022 |
SC 13G
| EcoR1 Capital, LLC reports a 5.5% stake in Springworks Therapeutics, Inc. |
| 06/27/2022 |
SC 13G
| EcoR1 Capital, LLC reports a 5.8% stake in Revolution Medicines, Inc. |
| 05/16/2022 |
SC 13G
| EcoR1 Capital, LLC reports a 5.9% stake in Arvinas, Inc. |
| 04/11/2022 |
SC 13G
| EcoR1 Capital, LLC reports a 6.3% stake in Reata Pharmaceuticals, Inc. |
| 03/14/2022 |
SC 13G
| EcoR1 Capital, LLC reports a 9.9% stake in Surface Oncology, Inc. |
| 02/14/2022 |
SC 13G
| EcoR1 Capital, LLC reports a 7.5% stake in Aligos Therapeutics, Inc. |
| 02/02/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 01/31/2022 |
SC 13G
| EcoR1 Capital, LLC reports a 6.8% stake in Kura Oncology, Inc. |
| 12/10/2021 |
SC 13G
| EcoR1 Capital, LLC reports a 6.5% stake in Atea Pharmaceuticals, Inc. |
| 11/16/2021 |
SC 13G
| EcoR1 Capital, LLC reports a 8.1% stake in 2seventy bio, Inc. |
| 10/22/2021 |
SC 13G
| EcoR1 Capital, LLC reports a 9.4% stake in Voyager Therapeutics, Inc. |
| 07/19/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 07/19/2021 |
SC 13G
| EcoR1 Capital, LLC reports a 6.4% stake in Arcus Biosciences, Inc. |
| 07/12/2021 |
SC 13G
| EcoR1 Capital, LLC reports a 6% stake in Alector, Inc. |
| 05/17/2021 |
SC 13G
| EcoR1 Capital, LLC reports a 7.9% stake in Shattuck Labs, Inc. |
| 05/11/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/16/2021 |
SC 13G
| EcoR1 Capital, LLC reports a 5.6% stake in Avidity Biosciences, Inc. |
| 02/16/2021 |
SC 13G
| EcoR1 Capital, LLC reports a 5.7% stake in Akouos, Inc. |
| 01/26/2021 |
SC 13G
| EcoR1 Capital, LLC reports a 6.8% stake in Infinity Pharmaceuticals, Inc. |
| 01/22/2021 |
SC 13G
| EcoR1 Capital, LLC reports a 6.6% stake in AC Immune SA |
|
|
|